Published: 10:02am, 30 Jul, 2018 Updated: 11:01pm, 30 Jul, 2018
China 's gene therapy market is predicted to grow from CNY7.2bn ( $ 1.06bn ) last year to CNY18.3bn by 2022 , thanks to increased investment from equipment makers and increased export income , according to Beijing - based CCID Consulting . The international market is currently worth $ 3bn , but Global Market Insights predicted it to expand to $ 22bn by 2020 . It is good news for firms such as Tencent - backed Centrillion , which has developed third - generation DNA - based semiconductor chips . It has two plants based in China and harbours hopes of achieving annual revenues of $ 5000 .